Open, hybrid or total minimally invasive esophagectomy; a comprehensive review based on a systematic literature search
Review Article

Open, hybrid or total minimally invasive esophagectomy; a comprehensive review based on a systematic literature search

William Jebril1,2, Fredrik Klevebro1,2, Ioannis Rouvelas1,2, Magnus Nilsson1,2

1Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Sweden; 2Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden

Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: W Jebril; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Prof. Magnus Nilsson. Karolinska University Hospital Huddinge, C177, 14186 Stockholm, Sweden. Email: magnus.nilsson@ki.se.

Abstract: Esophagectomy is the backbone of esophageal and gastroesophageal junction cancer with curative intention and the procedure is associated with significant risk for postoperative complications and mortality. Minimally invasive surgical techniques have been introduced with the aim to reduce morbidity and mortality. This review article has the objective to give an overview of the currently available evidence concerning the various techniques of minimally invasive esophagectomy (MIE) and their outcomes. A structured search of randomized controlled trials and large cohort studies published in the medical literature, comparing open and MIE techniques, was performed. Relevant studies were summarized, discussed and included in a comprehensive review based on the systematic literature search. MIE can be performed in various ways ranging from hybrid techniques to a totally minimally invasive approach. Increasingly also robotic surgical systems are being used. The published studies are somewhat ambiguous. Randomized trials report that MIE techniques are associated with a lower postoperative short-term morbidity and better short and medium term quality of life, compared to open esophagectomy (OE). Some population-based cohort studies suggest worse short-term outcomes after MIE. Most studies report long-term survival after MIE is at least similar to OE. The optimal surgical approach for esophageal cancer remains to be determined, but it is clear that MIE techniques will continue to develop and be an important part of treatment with curative intention in the future.

Keywords: Minimally invasive esophagectomy (MIE); robotic minimally invasive esophagectomy (RAMIE); hybrid minimally invasive esophagectomy (HMIE)


Received: 25 May 2020; Accepted: 24 June 2020; Published: 25 March 2021.

doi: 10.21037/aoe-2020-03


Introduction

Esophagectomy is associated with high risk for postoperative complications compared to other types of surgery, and it is essential to establish the most favorable surgical approach in terms of short-term postoperative outcomes, long-term health-related quality of life (HRQOL) and survival.

In 1992 Sir Alfred Cuschieri in Dundee, Scotland, reported the first series of five successful thoracoscopically-assisted esophagectomies by performing thoracoscopy in prone position and then laparotomy in a three-stage approach similar to the open technique described by McKeown (1). Since then, a variety of minimally invasive esophagectomy (MIE) techniques have emerged. A range of hybrid techniques combining open surgery with some type of minimally invasive approach to a total minimally invasive procedure have been described over the years. Several types of positioning (prone, semi-prone, left lateral) during thoracoscopy as well as various approaches (two-stage, three-stage) have been implemented. Additionally, in recent years robot-assisted MIE (RAMIE) has become increasingly popular.

In this review, we present a comprehensive summary of a systematic search of the published scientific literature and discuss the three main surgical approaches currently used; open esophagectomy (OE), totally minimal invasive esophagectomy (TMIE), and hybrid MIE (HMIE), including robot-assisted techniques.


Literature search

A literature search was conducted to identify relevant studies in PubMed, Web of Science, Embase and Cochrane. The following search terms were used: “esophagectomy”, “esophagectomies”, “minimally invasive procedures”, “laparoscopy”, “minimal*invasive”, “minimal access”, “minimal*surg”, “minimal*surgical” or “hybrid”. Inclusion criteria were: (I) studies published in English language, (II) randomized controlled trials (RCTs) or cohort studies (prospective and retrospective) comparing outcomes between OE, TMIE or HMIE. Uncontrolled case series were excluded. When duplicate studies were identified the most recent study was included.

The first search resulted in 918 articles. After a review of titles, abstracts, and in some cases full-text articles, 186 studies were chosen for review. In the second step, commentaries, case-reports, meta-analyses, and review articles were excluded, totaling 121 articles remaining (Figure 1). In a third step, RCTs, and large cohort studies were selected for final inclusion in the review. An additional study, published after the search, was added at the time the editing process took place. Details of the included studies are presented in Table 1.

Figure 1 PRISMA flow diagram.
Table 1
Table 1 Summary data of included randomized clinical trials and population-based cohort studies comparing open and minimally invasive esophagectomy
Full table

OE versus MIE techniques in general

OE has been gold standard in the treatment of esophageal cancer for many years and is still a valid and effective treatment. However, a disadvantage with OE is the need for large surgical incisions including laparotomy in the upper abdominal midline and thoracotomy with concurrent traumatic rib spreading. MIE with video-assisted guidance offers several (at least theoretical) advantages including smaller incisions, magnification of the operative field and improved visual resolution, but relevant (clinical) benefits on the patient level remain unclear.

The studies referred to below report the results of comparisons between OE and a mix of HMIE and TMIE, which consequently makes the interpretation of the results more complex. In a British population-based study there was no difference in in overall morbidity or 30-day mortality between mixed MIE techniques and OE, while a higher reintervention rate was documented in the MIE group, which may to some extent be influenced by the learning curve for MIE (10). In a nationwide Japanese study better short-term outcomes, especially less respiratory complications, was reported after procedures with mixed MIE techniques compared to OE. There was also markedly less blood loss, but longer operation time and more reoperations after MIE, while there was no difference in postoperative mortality (12). In another Japanese population-based cohort study including 24,233 esophagectomies it was confirmed that MIE techniques were superior or at least equivalent to OE regarding postoperative morbidity and mortality (11). In an American study based on the National Cancer Data Base a significantly higher number of lymph nodes were retrieved using MIE techniques and a shorter hospital length of stay compared to OE. Tumor-free resection margins, readmissions, 30-day mortality and 3-year survival were similar between the groups and the study concluded that MIE for esophageal cancer was associated with improved perioperative outcome without compromising survival (3). A more recent study using the same database also confirmed that MIE appears to have equivalent oncological outcomes and survival when compared with the open approach (4) (Table 1).


OE compared to totally minimal invasive esophagectomy

There are a number of TMIE options. First, Ivor Lewis TMIE, which is considered technically challenging since the intrathoracic anastomosis must be performed thoracoscopically. This procedure is started with a laparoscopic gastric mobilization and abdominal lymph node dissection performed with the patient in supine position. Secondly, the patient is turned to either prone, semi-prone or left lateral decubitus position in order to gain thoracoscopic access in the right chest cavity. Another TMIE option, minimizing invasiveness even more, is transhiatal laparoscopic TMIE, mimicking open transhiatal esophagectomy, is performed with laparoscopic mobilization of the stomach and gastroesophageal junction followed by transhiatal dissection of the lower mediastinum, followed by a conventional left-sided cervical incision and an upper-midline mini laparotomy. The completion of the upper mediastinal dissection is usually accomplished by blunt manual dissection and use of so-called stripping technique, in the same manner as in open transhiatal esophagectomy. Lastly, the three-stage TMIE according to McKeown, was the first MIE technique that was popularized. The McKeown TMIE starts with thoracoscopic mobilization of the esophagus along with dissection of mediastinal lymph nodes with the patient in prone, semi-prone or left lateral decubitus position. The patient is then turned to supine position and laparoscopy with gastric mobilization and abdominal lymph node dissection is performed. The last step is a cervical incision through which the anastomosis between the proximal esophagus and the pulled-up gastric conduit is completed (20).

TMIE has been shown to be feasible for all patients regardless of age, tumor size and physiological fitness (21). The European multicenter TIME trial, was the first (relatively small) RCT to compare OE and TMIE. The study showed less pulmonary infections after surgery and shorter hospital stay in the TMIE group, while lymph node yield and R0 rate, were similar in both groups. At follow-up 6 weeks after surgery all aspects of HRQOL, with exception of the mental component, HRQOL was better among patients who had undergone TMIE compared to those after OE (8). Subsequent publications from this trial revealed a HRQOL advantage after TMIE at one year follow-up (7), while there was no significant difference in disease-free 3-year survival (19). A sub-study of the trial investigated the immunological changes after TMIE in comparison to OE and demonstrated significant differences, with lower leukocyte counts, IL-8, and prolactin at 1 week postoperatively in the TMIE group (9), suggesting reduced inflammatory, and possibly less prominent immune system affection.

A recent Swedish-Finnish population-based study compared short-term outcomes following both Ivor Lewis and McKeown type TMIE and OE for cancer, and showed reduced 90-day mortality, shorter hospital stay, and lower 30-day readmission rates after TMIE compared to OE (13). In another population-based Swedish-Finnish study from the same group, the incidence of anastomotic strictures, comparing TMIE and OE, was reported, with a more frequent need for repeated dilatations after TMIE compared to OE (14).

In a comparative study between TMIE and OE based on the American Society of Thoracic Surgeons National Database from 2016, postoperative morbidity and mortality were equivalent between the groups, while TMIE was associated with longer procedure times, but shorter median length of hospital stay. As demonstrated in other studies, patients who underwent TMIE had higher rates of reoperation, while OE was associated with higher rates of wound infections, ileus and postoperative blood transfusions. High- and low-volume centers had similar outcomes. The longer procedure times and reoperations in TMIE may reflect a learning curve. The study concluded that TMIE is safe and with comparable morbidity and mortality as OE (16).

Few population-based studies have addressed long-term survival comparing TMIE and OE, but in a Finnish population-based study TMIE was associated with improved 5-year survival compared to OE, while in this study, there were no significant differences in 30- and 90-day mortality (15). In a very recently published study examining the generalizability of the TIME trial results to clinical practice, trial outcomes were compared to Dutch population-based DUCA registry data (17). There was a discordance between trial and population-based study groups: there was an increased risk for overall and pulmonary complications after MIE, while R0 resection rate and lymph node yield were higher and 30-day mortality lower after MIE (17).

In summary, the only randomized trial comparing OE vs. conventional, non-robotic, TMIE demonstrated that TMIE is associated with reduced risk for pulmonary infections, better short and medium term HRQOL, and similar number of resected lymph nodes, which in turn may be a proxy for improved or at least not compromised oncological outcomes. A large population-based cohort study is equivocal, and in some cases even suggests worse short term outcome after TMIE. TMIE is often associated with longer operation time and increased risk for reoperation, which may to some extent reflect the considerable learning curve.


HMIE vs. OE

The definition of HMIE is the combination of open and minimally invasive surgical techniques in the same procedure, i.e., laparoscopy combined with thoracotomy or laparotomy with thoracoscopy. Mainly Ivor Lewis esophagectomy, using laparoscopic and conventional open thoracotomy access, is performed with HMIE, as this enables open intrathoracic anastomosis, which has been one of the main obstacles in the TMIE Ivor Lewis learning curve. Several studies have shown laparoscopy to be associated with better postoperative respiratory functions, compared to laparotomy (22,23). It is well established that an upper midline laparotomy can significantly affect respiratory function to a degree similar as a thoracotomy, and the combination of both may therefore account for some of the significant morbidity reported after OE (24,25). Consequently the main hypothesis justifying HMIE has been that large surgical incisions on both sides of the diaphragm may be associated with increased risk for postoperative complications. Thus, the single compartment minimally invasive approach used in HMIE may reduce this risk (26). HMIE has been used at many centers during the introduction and development of TMIE.

The MIRO trial is a recently published RCT comparing HMIE to OE. Patients with esophageal cancer of the middle or lower third of the esophagus were included. The primary endpoint was intraoperative or postoperative complications within 30 days classified as Clavien-Dindo grade II or higher. In total, 207 patients were randomly assigned to HMIE or OE from October 2009 through April 2012. A total of 37 patients (36%) in the HMIE group had a Clavien-Dindo grade II or higher complication, compared with 67 (64%) patients in the OE group (odds ratio, 0.31; 95% confidence interval: 0.18 to 0.55; P<0.001). Major pulmonary complications were decreased after HMIE, 18% vs. 30% in the OE group. At three years, overall survival was 67% (95% CI, 57 to 75) in the HMIE group, compared with 55% (95% CI, 45 to 64) in the open-procedure group, which however did not reach statistical significance (2). HRQOL was significantly improved at 30 days after HMIE compared to OE, specifically role functioning and social functioning domains (27). The results of the MIRO trial are in accordance with most data from cohort studies comparing HMIE to OE (28).

In conclusion, the results of the only currently available published RCT and the published population-based cohort studies, quite unanimously report that HMIE is associated with significant improvements in short-term outcomes compared to OE, and that the oncological outcome of the procedure is at least as good as after OE.


RAMIE

The application of robot-assisted surgery is promising and has shown its potential to increase accuracy in dissection through improved maneuverability and visualization. The DaVinci robotic system has been widely implemented in the fields of urology, rectal cancer surgery, and gynecology. One main benefit is that the robotic arms can articulate, thereby improving dexterity compared to conventional laparoscopic instruments. These movements can closely mirror open surgical technique, with the important advantage of minimized surgical access trauma. Possible advantages with RAMIE compared to other MIE techniques, is yet to be clarified, especially with regard to justifying the increased cost associated with robotic, compared to conventional, minimally invasive surgery. These costs may in the future be shown to be offset by further decreases in blood loss, postoperative morbidity and length of hospitalization, compared to conventional MIE (29).

In a subgroup analysis of a population-based study, published in 2016, RAMIE was compared with MIE. The results showed no differences between RAMIE and MIE in tumor free resection margin, resected lymph nodes, hospital length of stay, 30-day readmission or 30-day mortality. Interestingly the study revealed that after stratification by histologic type, there were no significant differences in 3-year survival between MIE and RAMIE for patients with adenocarcinoma. However, patients with squamous cell carcinoma who underwent RAMIE were reported to have significantly better survival at 2 years (3).

In a study from 2019 factors associated with conversion to open surgery in patients undergoing MIE and RAMIE, and the impact of conversion to open surgery on postoperative outcomes, were analyzed. In total 5.2% of the RAMIEs were converted to open, compared to 12.0% in the TMIE group. Conversion rates decreased significantly for both approaches over the study period, indicating that the study period included the learning curve for both the procedure types. High volume of performed cases and robotic approach were associated with decreased conversion rates, indicating that RAMIE may have a shorter learning curve than conventional MIE. Patients who had undergone conversion to OE had an increased 90-day mortality, prolonged hospital stay, and higher rates of unplanned readmission (5). Short-term outcomes in a South Korean propensity score matched cohort study of RAMIE vs. OE in squamous cell carcinoma patients from 2019 showed that the OE group had a higher incidence of pneumonia, higher requirement of vasopressors postoperatively, more pain and worse short-term HRQOL scores. Regarding long term survival, interestingly, all cause mortality was higher and disease-free survival was lower in the OE group compared to RAMIE (6). Similar findings, with better outcomes with regard to lower blood loss, less postoperative pain, shorter length of stay, less intensive care time after RAMIE compared to OE, has been reported from other comparative cohort studies (30,31).

Recently the first RCT comparing RAMIE to OE, the ROBOT trial, was published. The ROBOT trial, which was a single center trial from Utrecht, with a design similar to the TIME trial, compared three stage McKeown RAMIE to three stage McKeown OE after randomization of 112 esophageal cancer patients (18). The trial was positive regarding the primary endpoint postoperative Clavien-Dindo II-V complications, with significantly lower incidence of 59% in the RAMIE group vs. 80% in the OE group (P=0.02). Functional recovery and short term HRQOL was also better after RAMIE (18).

In conclusion, early outcomes of RAMIE seem to be equivalent to MIE, and share its advantages compared to OE. The indications in some studies that RAMIE might be superior to MIE are so far not based on adequate data of sufficient quality, and needs to be evaluated in future studies.


Discussion

The majority of the studies included in this review indicate that minimally invasive surgical techniques are associated with improved outcomes in esophageal and gastroesophageal junction cancer treatment. This may to some extent be influenced by bias from residual confounding and case selection for MIE. Interestingly, there is a discrepancy between the results of the three randomized trials so far published, which all very clearly show better short-term outcome after MIE, and population-based data. The latter suggest the opposite, with more overall and pulmonary complications after MIE. This discrepancy may reflect the problems of generalizability that may hamper randomized trials, as they are often performed at expert centers in a selected stratum of patients. The population-based studies are therefore an important complement and may reflect difficulties encountered in implementing complex new techniques in clinical practice outside selected high-volume centers.

Better short-term postoperative outcomes with reduced risk for respiratory complications and shorter length of hospital stay are important developments (8,12,13). The findings suggesting that MIE may be associated with increased numbers of resected lymph nodes and improved long-term survival (4,6,15,32) are promising, but still immature and need to be confirmed in large, well-designed population based studies, or ideally in a large, pragmatic multi-centric randomized phase III trial.

The negative aspects of MIE should also be highlighted. The procedure is complex and there is evidence that there is a long learning curve in the implementation of the technique (33) translated in higher risk for anastomotic leak and reoperation rates after MIE compared to OE (14).

A strength of this review is the focus on high-quality scientific evidence including only RCTs and comparative cohort studies. Limitations of the study include the relatively low number of RCTs in the field and the non-standardized reporting of postoperative complications after esophagectomy applied in most studies (34).

In conclusion, the available grade A evidence shows that minimally invasive surgical technique is associated with reduced postoperative morbidity and the MIRO trial even suggests that survival HMIE may be improved, compared to open surgery for esophageal and gastroesophageal junction cancer. However, the learning curve in the implementation of MIE needs to be addressed in order to avoid harm to patients when new surgeons and centers are introduced to the technique. RAMIE is a technical refinement of the MIE technique and future studies are needed if that refinement is associated with better outcomes in esophageal cancer treatment. The pursuit of better outcomes and lower mortality in the future will definitely include further implementation, and development of minimally invasive esophagectomy techniques.


Acknowledgments

We would like to acknowledge Heidi Simosdotter Marlisto and Eva Fjellgren at the Karolinska University Hospital Library in Solna and Huddinge, respectively. They were of great assistance in the electronic literature search.

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the Guest Editors (Sjoerd Lagarde, Bas Wijnhoven, and Florian Lordick) for the series “Novel Developments in the Multimodality Treatment of Esophageal Cancer” published in Annals of Esophagus. The article has undergone external peer review.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at: http://dx.doi.org/10.21037/aoe-2020-03). The series “Novel Developments in the Multimodality Treatment of Esophageal Cancer” was commissioned by the editorial office without any funding or sponsorship. MN serves as an unpaid editorial board member of Annals of Esophagus from Feb 2020 to Jan 2022. The authors have no other conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992;37:7-11. [PubMed]
  2. Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer. N Engl J Med 2019;380:152-62. [Crossref] [PubMed]
  3. Yerokun BA, Sun Z, Yang CFJ, et al. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. Ann Thorac Surg 2016;102:416-23. [Crossref] [PubMed]
  4. Mitzman B, Lutfi W, Wang CH, et al. Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database. Semin Thorac Cardiovasc Surg 2017;29:244-53. [Crossref] [PubMed]
  5. Halpern AL, Friedman C, Torphy RJ, et al. Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database. Surg Endosc 2020;34:3470-78. [Crossref] [PubMed]
  6. Yun JK, Chong BK, Kim HJ, et al. Comparative outcomes of robot-assisted minimally invasive versus open esophagectomy in patients with esophageal squamous cell carcinoma: a propensity score-weighted analysis. Dis Esophagus 2020;33:doz071. [Crossref] [PubMed]
  7. Maas KW, Cuesta MA, van Berge Henegouwen MI, et al. Quality of Life and Late Complications After Minimally Invasive Compared to Open Esophagectomy: Results of a Randomized Trial. World J Surg 2015;39:1986-93. [Crossref] [PubMed]
  8. Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomisedcontrolled trial. Lancet 2012;379:1887-92. [Crossref] [PubMed]
  9. Maas KW, Biere SS, van Hoogstraten IM, et al. Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial. World J Surg 2014;38:131-7. [Crossref] [PubMed]
  10. Mamidanna R, Bottle A, Aylin P, et al. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann Surg 2012;255:197-203. [Crossref] [PubMed]
  11. Yoshida N, Yamamoto H, Baba H, et al. Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database. Ann Surg 2020;272:118-24. [Crossref] [PubMed]
  12. Takeuchi H, Miyata H, Ozawa S, et al. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan. Ann Surg Oncol 2017;24:1821-7. [Crossref] [PubMed]
  13. Kauppila JH, Helminen O, Kytö V, et al. Short-Term Outcomes Following Minimally Invasive and Open Esophagectomy: A Population-Based Study from Finland and Sweden. Ann Surg Oncol 2018;25:326-32. [Crossref] [PubMed]
  14. Helminen O, Kytö V, Kauppila JH, et al. Population-based study of anastomotic stricture rates after minimally invasive and open oesophagectomy for cancer. BJS Open 2019;3:634-40. [Crossref] [PubMed]
  15. Sihvo E, Helminen O, Gunn J, et al. Long-term outcomes following minimally invasive and open esophagectomy in Finland: A population-based study. Eur J Surg Oncol 2019;45:1099-104. [Crossref] [PubMed]
  16. Sihag S, Kosinski AS, Gaissert HA, et al. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Comparison of Early Surgical Outcomes From The Society of Thoracic Surgeons National Database. Ann Thorac Surg 2016;101:1281-8; discussion 1288-9. [Crossref] [PubMed]
  17. Markar SR, Ni M, Gisbertz SS, et al. Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice. J Clin Oncol 2020;38:2130-9. [Crossref] [PubMed]
  18. van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial. Ann Surg 2019;269:621-30. [Crossref] [PubMed]
  19. Straatman J, van der Wielen N, Cuesta MA, et al. Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial. Ann Surg 2017;266:232-6. [Crossref] [PubMed]
  20. Nilsson M, Kamiya S, Lindblad M, et al. Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer. J Thorac Dis 2017;9:S817-25. [Crossref] [PubMed]
  21. Bailey L, Khan O, Willows E, et al. Open and laparoscopically assisted oesophagectomy: a prospective comparative study. Eur J Cardiothorac Surg 2013;43:268-73. [Crossref] [PubMed]
  22. Coelho JC, de Araujo RP, Marchesini JB, et al. Pulmonary function after cholecystectomy performed through Kocher’s incision, a mini-incision, and laparoscopy. World J Surg 1993;17:544-6. [Crossref] [PubMed]
  23. Frazee RC, Roberts JW, Okeson GC, et al. Open versus laparoscopic cholecystectomy. A comparison of postoperative pulmonary function. Ann Surg 1991;213:651-3; discussion 653-4. [Crossref] [PubMed]
  24. Ford GT, Whitelaw WA, Rosenal TW, et al. Diaphragm function after upper abdominal surgery in humans. Am Rev Respir Dis 1983;127:431-6. [Crossref] [PubMed]
  25. Simonneau G, Vivien A, Sartene R, et al. Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain. Am Rev Respir Dis 1983;128:899-903. [PubMed]
  26. Voron T, Lintis A, Piessen G. Hybrid esophagectomy. J Thorac Dis 2019;11:S723-7. [Crossref] [PubMed]
  27. Mariette C, Markar S, Dabakuyo-Yonli TS, et al. Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial. Ann Surg 2020;271:1023-9. [Crossref] [PubMed]
  28. Glatz T, Marjanovic G, Kulemann B, et al. Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patients. Langenbecks Arch Surg 2017;402:323-31. [Crossref] [PubMed]
  29. Boone J, Schipper MEI, Moojen WA, et al. Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg 2009;96:878-86. [Crossref] [PubMed]
  30. Sarkaria IS, Rizk NP, Goldman DA, et al. Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. Ann Thorac Surg 2019;108:920-8. [Crossref] [PubMed]
  31. Jeong DM, Kim JA, Ahn HJ, et al. Decreased Incidence of Postoperative Delirium in Robot-assisted Thoracoscopic Esophagectomy Compared With Open Transthoracic Esophagectomy. Surg Laparosc Endosc Percutan Tech 2016;26:516-22. [Crossref] [PubMed]
  32. Gottlieb-Vedi E, Kauppila JH, Malietzis G, et al. Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis. Ann Surg 2019;270:1005-17. [Crossref] [PubMed]
  33. van Workum F, Stenstra MHBC, Berkelmans GHK, et al. Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study. Ann Surg 2019;269:88-94. [Crossref] [PubMed]
  34. Low DE, Alderson D, Cecconello I, et al. International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg 2015;262:286-94. [Crossref] [PubMed]
doi: 10.21037/aoe-2020-03
Cite this article as: Jebril W, Klevebro F, Rouvelas I, Nilsson M. Open, hybrid or total minimally invasive esophagectomy; a comprehensive review based on a systematic literature search. Ann Esophagus 2021;4:9.